TCL Archive Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure By Cancer History Project December 5, 2014
TCL Archive Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light By Cancer History Project December 5, 2014
TCL Archive Varmus’s 2016 Bypass Budget Seeks “Modest” Increase of $823 Million By Cancer History Project December 5, 2014
TCL Archive NYC Doctor Pays $2.35 Million To Settle False Claims Act Suit Over Radiosurgery Reimbursements By Cancer History Project December 5, 2014
TCL Archive Drugs and Targets: Blincyto granted accelerated approval in R/R ALL By Cancer History Project December 5, 2014
TCL Archive In Brief: David Chambers named deputy director for implementation science at NCI DCCPS By Cancer History Project December 5, 2014
TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III By Cancer History Project November 28, 2014
TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer By Cancer History Project November 28, 2014
